Rising Public Interest in Weight Loss Medications and Growing Awareness of Their Aesthetic Sequelae: An Infodemiologic Google Trends Analysis and Clinical Diagnostic Patterning
ABSTRACT Background Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have gained rapid popularity for both medical and consumer-directed weight loss. This growth has been accompanied by increased public discussion regarding facial aesthetic changes, commonly referred to as “Ozempic face,” characterized by volume depletion and cutaneous laxity. Objective To quantify temporal patterns of public search interest in […]
How Ozempic and Wegovy are quietly cutting America’s food bills
Weight-loss drugs like Ozempic and Wegovy are changing how Americans spend money on food. A large Cornell study found households cut grocery spending by over 5% within six months, with even bigger drops at fast-food restaurants. Snack foods and sweets saw the steepest declines, while only a few categories like yogurt and fruit rose slightly. The effects linger for at least a year among continued users.
Does Ozempic need to be taken forever once started? UK surgeon explains the effects of stopping GLP-1 drugs
According to Dr Rajan, GLP-1 drugs such as Ozempic is not designed for long-term weight loss, which requires a comprehensive approach.
Skin Reactions Uncommon but Vary by GLP-1 RAs
Cutaneous adverse events associated with GLP-1 receptor agonists are uncommon but vary by agent, a study of FDA data shows. Medscape Medical News
The humble egg: A natural, affordable ally in the battle against weight regain
(NaturalNews) A leading nutrition scientist proposes eggs as a key dietary tool for people stopping GLP-1 agonist drugs (like Ozempic) to help prevent the signi…
$SPY & $SPX — Weekly Market-Moving Headlines Jan 12–16, 2026
$SPY & $SPX — Weekly Market-Moving Headlines Jan 12–16, 2026 SPDR S&P 500 ETF Trust BATS:SPY TrendTao 🔮 SPY & SPX — Weekly Market-Moving Headlines Jan 12–16, 2026 🌍 Market-Moving Themes ⚛️ AI Power Arms Race Big Tech pre-buys nuclear capacity → OKLO SMR LEU sympathy stays in focus 🏠 Housing Stimulus Watch Mortgage-bond intervention […]
Bonus Features – January 11, 2026 – 64% of healthcare orgs lack AI anomaly detection, AI made up 46% of all healthcare tech investments in 2025, plus 33 more stories
Welcome to the weekly edition of Healthcare IT Today Bonus Features. This article will be a weekly roundup of interesting stories, product announcements, new hires, partnerships, research studies, awards, sales, and more. Because there’s so much happening out there in healthcare IT we aren’t able to cover in our full articles, we still want to […]
Plastic Surgeons Are Using Material From Dead People on New Patients
Cosmetic surgeons have turned to using a “fat filler” harvested from dead people in order to give patients new breasts, sexier buttocks and other body contouring tweaks, according to reporting by Business Insider — in a practice that not even “Frankenstein” author Mary Shelley could have dreamed up in her day. The hot new product […]
Novo Nordisk executive reports high interest for once-daily, oral weight-loss pill
Wegovy’s oral version of its injectable weight-loss drug is seeing tremendous interest, Novo Nordisk executive Dave Moore told FOX Business on Friday. Wegovy’s once-daily pill, an oral spin-off of its injectable weight loss medication, was approved in December 2025 by the Food and Drug Administration as the first oral GLP-1 drug and launched on U.S. […]
The launch of the world’s first weight-loss pill
Bad news for all those who have been trying to make “Jabuary” a thing, said Angus Colwell in The Spectator. The launch of the world’s first weight-loss pill – which has gone on sale in the US at a fraction of the cost of injectable versions – has rather stolen their thunder. Patients used to […]